Healthcare provider profile · identity verified

Jorge L Villacorta, MD

Family Practice · ROCKFORD, IL · NPI 1124064001

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	212
Lisinopril	Lisinopril	635	183
Amlodipine Besylate	Amlodipine Besylate	527	147
Metformin Hcl	Metformin Hcl	411	114
Levothyroxine Sodium	Levothyroxine Sodium	330	91
Hydrochlorothiazide	Hydrochlorothiazide	321	86
Losartan Potassium	Losartan Potassium	304	80
Omeprazole	Omeprazole	261	74
Albuterol Sulfate Hfa	Albuterol Sulfate	195	57
Metoprolol Succinate	Metoprolol Succinate	193	58
Gabapentin	Gabapentin	167	39
Tamsulosin Hcl	Tamsulosin Hcl	155	46
Metoprolol Tartrate	Metoprolol Tartrate	144	43
Glipizide Er	Glipizide	119	37
Rosuvastatin Calcium	Rosuvastatin Calcium	116	36
Simvastatin	Simvastatin	116	32
Furosemide	Furosemide	109	34
Tramadol Hcl	Tramadol Hcl	105	28
Clopidogrel	Clopidogrel Bisulfate	103	33
Sertraline Hcl	Sertraline Hcl	102	26
Meloxicam	Meloxicam	101	39
Trazodone Hcl	Trazodone Hcl	94	17
Carvedilol	Carvedilol	92	30
Jardiance	Empagliflozin	89	22
Pantoprazole Sodium	Pantoprazole Sodium	88	30
Hydralazine Hcl	Hydralazine Hcl	78	23
Atenolol	Atenolol	70	17
Potassium Chloride	Potassium Chloride	70	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	26
Lovastatin	Lovastatin	67	20
Pravastatin Sodium	Pravastatin Sodium	66	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	22
Fluticasone Propionate	Fluticasone Propionate	64	26
Glipizide	Glipizide	64	21
Vitamin D2	Ergocalciferol (Vitamin D2)	62	18
Alendronate Sodium	Alendronate Sodium	60	16
Warfarin Sodium	Warfarin Sodium	58	17
Azithromycin	Azithromycin	56	53
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Allopurinol	Allopurinol	54	15
Hydroxyzine Hcl	Hydroxyzine Hcl	53	16
Escitalopram Oxalate	Escitalopram Oxalate	50	16
Quetiapine Fumarate	Quetiapine Fumarate	50	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	40
Citalopram Hbr	Citalopram Hydrobromide	49	17
Eliquis	Apixaban	46	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Enalapril Maleate	Enalapril Maleate	44	11
Alprazolam	Alprazolam	42	13
Finasteride	Finasteride	41	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	38
Metformin Hcl Er	Metformin Hcl	38	14
Mounjaro	Tirzepatide	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Irbesartan	Irbesartan	36	11
Famotidine	Famotidine	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Spironolactone	Spironolactone	33	16
Xarelto	Rivaroxaban	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	27
Ozempic	Semaglutide	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Prednisone	Prednisone	25	21
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Amoxicillin	Amoxicillin	21	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Fluconazole	Fluconazole	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Valsartan	Valsartan	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Nifedipine Er	Nifedipine	17	suppressed
Nabumetone	Nabumetone	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Clotrimazole	Clotrimazole	14	11
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error